Avidity Biosciences Inc
NASDAQ:RNA
Avidity Biosciences Inc
NASDAQ:RNA
Price:
13.23
USD
0.99%
Market Closed
Market Cap:
$10.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Avidity Biosciences Inc
NASDAQ:RNA
|
US |
|
Grupo Bursatil Mexicano SA de CV Casa de Bolsa
BMV:GBMO
|
MX |
|
Trisura Group Ltd
TSX:TSU
|
CA |
Balance Sheet
Balance Sheet Decomposition
Avidity Biosciences Inc
Avidity Biosciences Inc
Balance Sheet Decomposition is not available for
Avidity Biosciences Inc
Avidity Biosciences Inc
Balance Sheet
Avidity Biosciences Inc
Avidity Biosciences Inc
Currency: USD
| Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|
| Assets | ||||
| Total Receivables |
0
|
0
|
0
|
|
| Other Current Assets |
1
|
0
|
3
|
|
| Total Current Assets |
1
|
0
|
3
|
|
| PP&E Net |
9
|
7
|
6
|
|
| PP&E Gross |
9
|
7
|
6
|
|
| Accumulated Depreciation |
1
|
1
|
3
|
|
| Total Assets |
10
N/A
|
7
-30%
|
8
+16%
|
|
| Liabilities | ||||
| Accounts Payable |
0
|
1
|
4
|
|
| Accrued Liabilities |
5
|
5
|
16
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
28
|
21
|
22
|
|
| Total Current Liabilities |
34
|
27
|
42
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Other Liabilities |
47
|
41
|
29
|
|
| Total Liabilities |
81
N/A
|
68
-16%
|
71
+4%
|
|
| Equity | ||||
| Other Equity |
71
|
61
|
63
|
|
| Total Equity |
71
N/A
|
61
+13%
|
63
-3%
|
|
| Total Liabilities & Equity |
10
N/A
|
7
-30%
|
8
+16%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
17
|
17
|
17
|
|
Switch to:
Switch to:
See Also
Discover More
